Consulting glass experts – from the basic sand till the ultimate vial configuration of VIALEX
Primary packaging for pharmaceuticals is increasingly challenged to identify innovations that address industry concerns such as delamination while addressing ways to lower the total cost of ownership, specifically in the market of glass vials which is utilized extensively and has been a container of choice for decades. Many new solutions can be complex requiring extensive revalidation and additional risk to be taken upon by a pharmaceutical firm. Tackling these critical risk issues while balancing the push to reduce the total cost of ownership requires a collaborative relationship with your suppliers. How are you looking to your supplier to address these issues?
Through this webinar, you will learn how Nipro PharmaPackaging has created unique approaches through its Advanced Collaborations Taskforce (ACT) with pharmaceutical companies to identify and improve performance across a range of departments and processes. Attendees will learn about Nipro’s onsite Glass School intended to educate and align groups from various backgrounds on our integrated quality systems from raw material to finished product and how those systems can become an extension of yours. Nipro’s ACT team also supports process improvement opportunities with case studies to be shared showcasing throughput improvements on incoming inspection, production fill lines, and final product inspection systems.
Recent investments into R&D projects and Nipro’s Laboratory Services for Pharmaceutical Packaging will also showcase how partnering on a technical level can lead to further gains whether it be by performing drug and container stability testing, extractable/leachable studies, or leading the way in addressing industry critical concerns such as delamination and drug container stability issues with Nipro’s VIALEX® - the ultimate vial configuration for supreme performance. Partnering in early drug trial programs with Nipro will lead to identifying the proper vial configuration to decrease the time to market for your drug and ensure strong performance while maximizing shelf life during scale up, launch, and ongoing delivery to the healthcare industry.
Attendees will also learn more about the upcoming Nipro’s Customer Experience Days event to be held in conjunction with CPhI, in Philadelphia 2018, and how you can learn first-hand about how Nipro’s ACT team and recent innovations such as VIALEX®.
Presented by
Dave Lisman,
Strategic Projects Manager
Dave Lisman graduated with a Chemical Engineering degree from Bucknell University and later added an MBA from the Indiana University Kelley School of Business with a major in Finance. Dave has held several key positions over his 10+ years with Nipro first becoming a certified Lean Six Sigma Black Belt, followed by Production Manager, and Plant Manager positions for two of Nipro’s converting facilities. This experience has led him to his current position as Strategic Projects Manager.
In this position, Dave is responsible for technology development and global sharing of advances within the Nipro PharmaPackaging group, along with leading integral projects with customers focusing on chemical durability enhancements, throughput optimization, and design optimization. Dave also leads glass school events at pharmaceutical company locations to educate and align groups from various backgrounds on glass production & converting, highlighting ways to address and improve performance in the total lifecycle of the product and its packaging.
Dr Juan Cerdan-Diaz,
Director of R&D and Technical Services
Dr Cerdan-Diaz holds a BS in Chemical Engineering from the National Polytechnic Institute of Mexico and a Masters and PhD in Ceramics and Glass Science from Alfred University. He has over 30 years of experience in the glass and ceramics industry in the areas of Manufacturing, Engineering, R&D and Quality Assurance. His extensive experience includes technology transfer. He has been involved in the dental ceramics industry (medical devices, cGMP) as well as in the manufacturing of Magnesium Sulphate (parenteral, API, cGMP).
Over the last fifteen years, Dr Cerdan-Diaz has been involved in the manufacturing of glass packaging for the pharmaceutical and biological industries in the areas of Quality Assurance, R&D and Technical Services. He has authored/co-authored over 10 journal articles and has been granted three patents. He has worked with the PDA in the review of a Technical Report and is currently working with the USP in an Expert Panel. During the past seven years, Dr Cerdan-Diaz has been the Director of R&D and Technical Services for Nipro.
